Article

Establishment of murine hybridoma cells producing antibodies against spike protein of SARS-CoV-2

2020-08-29

Abstract excerpt

In 2020 the world faced the pandemic of COVID-19 - severe acute respiratory syndrome caused by a new type of coronavirus named SARS-CoV-2. To stop the spread of the disease, it is crucial to create molecular tools allowing to investigate, diagnose and treat COVID-19. One of such tools are monoclonal antibodies (mAbs). In this study we describe the development of hybridoma cells that can produce mouse mAbs against...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 144c1356-02d0-516c-a8d8-9ad2db8730be
DOI: 10.1101/2020.08.29.272963

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Establishment of murine hybridoma cells producing antibodies against spike protein of SARS-CoV-2DOI 10.1101/2020.08.29.272963Read

Isolation and characterization of neutralizing monoclonal antibodies from a large panel of murine antibodies against RBD of the SARS-CoV-2 Spike proteinSemantic proximity Read

Rapid Development of Neutralizing and Diagnostic SARS-COV-2 Mouse Monoclonal AntibodiesSemantic proximity Read

Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variantsSemantic proximity Read

A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike proteinSemantic proximity Read

Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 miceSemantic proximity Read

Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike proteinSemantic proximity Read

Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic AntibodiesSemantic proximity Read

Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variantsSemantic proximity Read

Monoclonal antibodies for the S2 subunit of spike of SARS-CoV cross-react with the newly-emerged SARS-CoV-2Semantic proximity Read

Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein.Semantic proximity Read

A Novel Neutralizing Antibody Targeting Receptor Binding Domain of SARS-CoV-2Semantic proximity Read

Recombinant SARS-CoV-2 spike proteins for sero-surveillance and epitope mappingSemantic proximity Read